EMBRAER S.A. - MATERIAL FACT
EMBRAER S.A. - MATERIAL FACT
PR Newswire
SÃO JOSE DOS CAMPOS, Brazil, Sept. 16, 2024
SÃO JOSE DOS CAMPOS, Brazil, Sept. 16, 2024 /PRNewswire/ --
EMBRAER S.A.
Publicly Held Company
CNPJ/MF: 07.689.002/0001-89
NIRE: 353.003.257-67
/PRNewswire/ -- EMBRAER S.A. ("Embraer") (B3: EMBR3, NYSE: ERJ), in attention to Resolution CVM nº 44/2021, informs its shareholders and the market in general that the pending arbitration proceedings between Embraer and its affiliates, on the one hand, and The Boeing Company ("Boeing") and its affiliates, on the other hand, have concluded.
Pursuant to a collar agreement recently entered into between the parties, Boeing will pay the gross amount of USD 150 million to Embraer.
São José dos Campos, September 16, 2024.
Antonio Carlos Garcia
Executive Vice President, Financial & Investor Relations
View original content:https://www.prnewswire.com/news-releases/embraer-sa---material-fact-302249070.html
SOURCE Embraer S.A.
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks